AN2 Therapeutics, Inc.

NasdaqGS:ANTX Stock Report

Market Cap: US$70.6m

AN2 Therapeutics, Inc. Company Information

AN2 Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: AN2 Therapeutics, Inc.
  • Ticker: ANTX
  • Exchange: NasdaqGS
  • Founded: 2017
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$70.556m
  • Shares Outstanding: 29.77m
  • Website: https://www.an2therapeutics.com

Number of Employees


Location

  • AN2 Therapeutics, Inc.
  • 1800 El Camino Real
  • Suite D
  • Menlo Park
  • California
  • 94027
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ANTXNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDMar 2022

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/04/24 00:00
End of Day Share Price 2024/04/24 00:00
Earnings2023/12/31
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.